Enliven Therapeutics logo
Enliven Therapeutics
ELVN | NASDAQ
Chart Builder DCF Calculator
$47.62
-$1.18 (-2.42%)
At close: Nov 16, 2026, 4:00 PM ET
$47.62
$0.00 (0.00%)
After-hours: Nov 16, 2026, 7:30 PM ET

Enliven Therapeutics Income Statement

Income statement explained
Fiscal Year
Period Ending
FY 2025
Dec 31, 2025
FY 2024
Dec 31, 2024
FY 2023
Dec 31, 2023
FY 2022
Dec 31, 2022
FY 2021
Dec 31, 2021
FY 2020
Dec 31, 2020
– – – – – –
263K – – – – –
-263K – – – – –
-119.66M -104.55M -83.53M -38.79M -24.76M -9.32M
16.01M 14.89M 11.97M 1.13M 22K 483K
-103.69M -88.79M -71.58M -37.66M -24.74M -18.97M
-103.69M -89.02M -71.58M -37.66M -24.74M -18.97M
33.8M 23.78M 18.96M 7.77M 4.29M 1.08M
85.86M 80.78M 64.57M 31.02M 20.47M 8.24M
– – – – – –
119.4M 104.55M 83.53M 38.79M 24.76M 9.32M
– – – – – –
– – – – – –
119.66M 104.55M 83.53M 38.79M 24.76M 9.32M
– 232K – – – –
56.66M 47.07M 35.55M 6.25M 7.81M 4.39M
56.66M 47.07M 35.55M 6.25M 7.82M 4.39M
-1.83 -1.89 -2.01 -6.03 -3.17 -4.31
-1.83 -1.89 -2.01 -6.03 -3.17 -4.31
-103.43M -88.48M -71.29M -37.45M -24.63M -9.27M
-103.69M -88.79M -71.58M -37.66M -24.74M -9.32M
263K 317K 297K 215K 115K 45K

© 2026 bestshares.com. All rights reserved.

All data is for informational purposes only. bestshares.com is not a broker, dealer, or registered investment adviser, and nothing on this site is a recommendation to buy or sell any security.